Search

everythinglearnresearchcommunity

for

Search:↓

5% topical minoxidil improves hair density and quality in monilethrix patients.

Recognizing minor skin lesions can help identify serious cancer syndromes.

Using 0.1 mg·L–1 molybdenum improves melon growth, quality, and yield under high heat.

Moles may stop growing due to cell cooperation, not just because of individual cell aging.

Mice without the vitamin D receptor are more prone to UV-induced skin tumors.

Melanin may help melanoma cells grow by aiding their metabolism.

A specially designed molybdenum oxide nanozyme can treat and monitor acute kidney injury effectively.

The MDR1 C3435T polymorphism does not significantly affect methotrexate response in rheumatoid arthritis patients.

Some people have a genetic variation that makes them less effective at breaking down drugs.

Disrupting Bcl-xL in mice reduces skin cancer risk.

Hispanic patients in the USA have lower survival rates for melanoma compared to non-Hispanic Whites.

Mitochondria may influence how cells respond to radiation, affecting nearby non-irradiated cells.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe side effects.

Androgen receptor inactivation delays skin cancer onset and reduces incidence in mice, with gender differences in susceptibility.

Control variability makes it hard to confirm low-dose endocrine effects.

Both enzyme forms can sulfate minoxidil.

A rare genetic variant linked to skin cysts was found in blood DNA, suggesting its role in cyst formation.

Two new compounds were found to effectively reduce hair growth in mice.

Genetic differences affect breast cancer treatment success with tamoxifen in South African patients.

Monilethrix is a rare genetic hair disorder with no cure, but low-dose oral minoxidil may help.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Tanning ability is linked to specific DNA changes in skin genes.

Monilethrix severity varies and may be influenced by other genetic or environmental factors.

The document concludes that more research is needed to reduce frequent hospital visits, addiction medicine education improves with specific training, early breast cancer surgery findings are emerging, nipple smears are not very accurate, surgery for older melanoma patients doesn't extend life, a genetic condition in infants can often be treated with one drug, doctors are inconsistent with blood clot medication, a certain gene may protect against cell damage, muscle gene overexpression affects many other genes, and some mitochondrial genes are less active in mice with tumors.

Melanoma risk tools need improvement, certain gene mutations cause skin diseases and could be treated by targeting those mutations, skin wrinkling may relate to lung aging due to genetic factors, and oxidative stress affects hair loss but can be reduced in low oxygen.

Some Greek melanoma patients have gene mutations linked to increased cancer risk, a new color feature helps diagnose melanoma, the incidence of a skin condition in the Netherlands is rare, and a gene possibly affects male-pattern baldness.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe symptoms and organ damage in mice.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.